{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T02:24:11Z","timestamp":1777775051415,"version":"3.51.4"},"reference-count":30,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T00:00:00Z","timestamp":1620432000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Background.<\/jats:bold>\n                    Renal transplant recipients are at increased risk for developing complications of vaccine-preventable diseases. They benefit from a comprehensive pre-transplant evaluation when they might safely receive live vaccines. The primary aim of our study was to investigate the number of renal transplant recipients who were evaluated for serologic status against measles, mumps, rubella (MMR), and varicella. Secondarily, we investigated if pre-transplant Infectious Diseases consultation (IDC) improved vaccination rates.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods.<\/jats:bold>\n                    We retrospectively analyzed 282 kidney-alone and kidney-plus adult transplant recipients who were born in or after 1957. Patients were evaluated at Mayo Clinic, Florida Transplant Center between January 2015 and December 2017. Serologic status evaluation and vaccination rates were compared in two groups created based on IDC and no ID consultation (NIDC).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results.<\/jats:bold>\n                    235 (83%) of a total 282 patients received an IDC pre-transplantation. Varicella IgG levels were screened in all 235 IDC candidates. Among the IDC patients, mumps, measles and rubella IgG serologies were performed in 7 (3%), 143 (61%) and 144 (61%), respectively. Among 44 patients seronegative for any of MMR, 24 (55%) were vaccinated. Ten (66%) of 15 varicella seronegative patients were vaccinated. Zostavax was not given to 18% of IDC patients. Zostavax and MMR were administered more frequently in the IDC group compared to NIDC (p &lt; .001 and p = 0.0016, respectively).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion.<\/jats:bold>\n                    Although the majority of patients had IDC, the screening rate for MMR serologies was lower than varicella. A protocol-driven serologic screening similar to the one for VZV is required for MMR. Pre-transplant IDC increases vaccination rates.\n                  <\/jats:p>","DOI":"10.2478\/rjim-2020-0036","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T15:08:31Z","timestamp":1606748911000},"page":"159-165","source":"Crossref","is-referenced-by-count":0,"title":["Serologic screening and infectious diseases consultation in renal transplant candidates for measles, mumps, rubella and varicella"],"prefix":"10.2478","volume":"59","author":[{"given":"Zeynep Idil","family":"Seckin","sequence":"first","affiliation":[{"name":"Department of Internal Medicine , Mayo Clinic , Jacksonville , Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia R.","family":"Libertin","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Mayo Clinic , Jacksonville , Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"Brumble","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Mayo Clinic , Jacksonville , Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2021,5,8]]},"reference":[{"key":"2026042913132148722_j_rjim-2020-0036_ref_001_w2aab3b7b2b1b6b1ab1ab1Aa","unstructured":"1. UNITED NETWORK FOR ORGAN SHARING. Organ donation again sets record in 2019. UNOS 2020. https:\/\/unos.org\/news\/organ-donation-sets-record-in-2019\/."},{"key":"2026042913132148722_j_rjim-2020-0036_ref_002_w2aab3b7b2b1b6b1ab1ab2Aa","unstructured":"2. SARAN R, ROBINSON B, ABBOTT KC, AGODOA LYC, BRAGG-GRESHAM J, BALKRISHNAN R, et al. US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. American Journal of Kidney Diseases 2019; 73:A7\u20138."},{"key":"2026042913132148722_j_rjim-2020-0036_ref_003_w2aab3b7b2b1b6b1ab1ab3Aa","doi-asserted-by":"crossref","unstructured":"3. SESTER M, G\u00c4RTNER BC, GIRNDT M, SESTER U. Vaccination of the solid organ transplant recipient. Transplantation Reviews 2008; 22:274\u201384.10.1016\/j.trre.2008.07.00118684606","DOI":"10.1016\/j.trre.2008.07.001"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_004_w2aab3b7b2b1b6b1ab1ab4Aa","doi-asserted-by":"crossref","unstructured":"4. GANGAPPA S, KOKKO KE, CARLSON LM, GOURLEY T, NEWELL KA, PEARSON TC, et al. Immune responsiveness and protective immunity after transplantation. Transplant International 2008; 21:293\u2013303.10.1111\/j.1432-2277.2007.00631.x18225995","DOI":"10.1111\/j.1432-2277.2007.00631.x"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_005_w2aab3b7b2b1b6b1ab1ab5Aa","doi-asserted-by":"crossref","unstructured":"5. VAN KESSEL DA, HOFFMAN TW, VAN VELZEN-BLAD H, VAN DE GRAAF EA, GRUTTERS JC, RIJKERS GT. Immune status assessment in adult lung transplant candidates. Transplant Immunology 2017; 40:31\u20134.10.1016\/j.trim.2016.11.00127867073","DOI":"10.1016\/j.trim.2016.11.001"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_006_w2aab3b7b2b1b6b1ab1ab6Aa","doi-asserted-by":"crossref","unstructured":"6. LOPEZ A, MARIETTE X, BACHELEZ H, BELOT A, BONNOTTE B, HACHULLA E, et al. Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis. Journal of Autoimmunity 2017; 80:10\u201327.10.1016\/j.jaut.2017.03.01128381345","DOI":"10.1016\/j.jaut.2017.03.011"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_007_w2aab3b7b2b1b6b1ab1ab7Aa","doi-asserted-by":"crossref","unstructured":"7. DANZINGER-ISAKOV L, KUMAR D. Guidelines for Vaccination of Solid Organ Transplant Candidates and Recipients. American Journal of Transplantation 2009; 9:S258\u201362.10.1111\/j.1600-6143.2009.02917.x20070687","DOI":"10.1111\/j.1600-6143.2009.02917.x"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_008_w2aab3b7b2b1b6b1ab1ab8Aa","doi-asserted-by":"crossref","unstructured":"8. PITTET LF, VEROLET CM, MCLIN VA, WILDHABER BE, RODRIGUEZ M, CHERPILLOD P, et al. Multimodal safety assessment of measles-mumps-rubella vaccination after pediatric liver transplantation. American Journal of Transplantation 2018; 19:844\u201354.10.1111\/ajt.1510130171797","DOI":"10.1111\/ajt.15101"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_009_w2aab3b7b2b1b6b1ab1ab9Aa","doi-asserted-by":"crossref","unstructured":"9. RODRIGUEZ-MORENO A, SANCHEZ-FRUCTUOSO AI, CALVO N, RIDAO N, CONESA J, MARQUES M, et al. Varicella Infection in Adult Renal Allograft Recipients: Experience at One Center. Transplantation Proceedings 2006; 38:2416\u20138.10.1016\/j.transproceed.2006.08.06017097954","DOI":"10.1016\/j.transproceed.2006.08.060"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_010_w2aab3b7b2b1b6b1ab1ac10Aa","doi-asserted-by":"crossref","unstructured":"10. GREENDYKE WG, PEREIRA MR. Infectious Complications and Vaccinations in the Posttransplant Population. Medical Clinics of North America 2016; 100:587\u201398.10.1016\/j.mcna.2016.01.00827095647","DOI":"10.1016\/j.mcna.2016.01.008"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_011_w2aab3b7b2b1b6b1ab1ac11Aa","doi-asserted-by":"crossref","unstructured":"11. DEPLEDGE DP, BROWN J, MACANOVIC J, UNDERHILL G, BREUER J. Viral Genome Sequencing Proves Nosocomial Transmission of Fatal Varicella. Journal of Infectious Diseases 2016; 214:1399\u2013402.10.1093\/infdis\/jiw398507937727571904","DOI":"10.1093\/infdis\/jiw398"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_012_w2aab3b7b2b1b6b1ab1ac12Aa","doi-asserted-by":"crossref","unstructured":"12. KAUSZ A, PAHARI D. The Value of Vaccination in Chronic Kidney Disease. Seminars in Dialysis 2004; 17:9\u201311.10.1111\/j.1525-139X.2004.17104.x","DOI":"10.1111\/j.1525-139X.2004.17104.x"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_013_w2aab3b7b2b1b6b1ab1ac13Aa","doi-asserted-by":"crossref","unstructured":"13. ABAD CL, RAZONABLE RR. \u03b1 Herpes Virus Infections Among Renal Transplant Recipients. Seminars in Nephrology 2016; 36:344\u201350.10.1016\/j.semnephrol.2016.05.01127772619","DOI":"10.1016\/j.semnephrol.2016.05.011"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_014_w2aab3b7b2b1b6b1ab1ac14Aa","doi-asserted-by":"crossref","unstructured":"14. KAUL A, SHARMA RK, BHADHURIA D, GUPTA A, PRASAD N. Chickenpox infection after renal transplantation. Clinical Kidney Journal 2012; 5:203\u20136.10.1093\/ckj\/sfs036440051026069765","DOI":"10.1093\/ckj\/sfs036"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_015_w2aab3b7b2b1b6b1ab1ac15Aa","doi-asserted-by":"crossref","unstructured":"15. LEE DH, BOYLE SM, MALAT G, SHARMA A, BIAS T, DOYLE AM. Low rates of vaccination in listed kidney transplant candidates. Transplant Infectious Disease 2016; 18:155\u20139.10.1111\/tid.1247326461052","DOI":"10.1111\/tid.12473"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_016_w2aab3b7b2b1b6b1ab1ac16Aa","doi-asserted-by":"crossref","unstructured":"16. CAMARGO LF, LOTHER AM, MAZZALI M, STUCCHI RSB. Immunization in end stage renal disease: The perception of waiting list patients. Transplant Infectious Disease 2018; 20:e12831.10.1111\/tid.1283129337400","DOI":"10.1111\/tid.12831"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_017_w2aab3b7b2b1b6b1ab1ac17Aa","doi-asserted-by":"crossref","unstructured":"17. KRUEGER KM, ISON MG, GHOSSEIN C. Practical Guide to Vaccination in All Stages of CKD, Including Patients Treated by Dialysis or Kidney Transplantation. American Journal of Kidney Diseases 2020; 75:417\u201325.10.1053\/j.ajkd.2019.06.01431585683","DOI":"10.1053\/j.ajkd.2019.06.014"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_018_w2aab3b7b2b1b6b1ab1ac18Aa","unstructured":"18. CHATENOUD L, HERBELIN A, BEAURAIN G, DESCAMPS-LATSCHA B. Immune Deficiency of the Uremic Patient. In: Gr\u00fcnfeld J-P, editor. Advances in Nephrology from the Necker Hospital, Chicago: Year Book Medical Publ; 1990, p. 259\u201374."},{"key":"2026042913132148722_j_rjim-2020-0036_ref_019_w2aab3b7b2b1b6b1ab1ac19Aa","doi-asserted-by":"crossref","unstructured":"19. JOHNSON DW, FLEMING SJ. The Use of Vaccines in Renal Failure. Clinical Pharmacokinetics 1992; 22:434\u201346.10.2165\/00003088-199222060-000031587056","DOI":"10.2165\/00003088-199222060-00003"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_020_w2aab3b7b2b1b6b1ab1ac20Aa","doi-asserted-by":"crossref","unstructured":"20. FUCHSHUBER A, KUHNEMUND O, KEUTH B, LUTTICKEN R, MICHALK D, QUERFELD U. Pneumococcal vaccine in children and young adults with chronic renal disease. Nephrology Dialysis Transplantation 1996; 11:468\u201373.10.1093\/oxfordjournals.ndt.a027313","DOI":"10.1093\/oxfordjournals.ndt.a027313"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_021_w2aab3b7b2b1b6b1ab1ac21Aa","doi-asserted-by":"crossref","unstructured":"21. TSUJIMURA K, OTA M, CHINEN K, NAGAYAMA K, OROKU M, SHIOHIRA Y, et al. Effect of Influenza Vaccine in Patients With Kidney Transplant. Transplantation Proceedings 2018; 50:2443\u20136.10.1016\/j.transproceed.2018.02.18630316375","DOI":"10.1016\/j.transproceed.2018.02.186"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_022_w2aab3b7b2b1b6b1ab1ac22Aa","doi-asserted-by":"crossref","unstructured":"22. H\u00d6CKER B, AGUILAR M, SCHNITZLER P, PAPE L, BALD M, K\u00d6NIG J, et al. Vaccination titres pre- and post-transplant in paediatric renal transplant recipients and the impact of immunosuppressive therapy. Pediatric Nephrology 2018; 33:897\u2013910.10.1007\/s00467-017-3868-029322328","DOI":"10.1007\/s00467-017-3868-0"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_023_w2aab3b7b2b1b6b1ab1ac23Aa","doi-asserted-by":"crossref","unstructured":"23. CHESDACHAI S, KLINE S, HELMIN D, RAJASINGHAM R. The Effect of Infectious Diseases Consultation on Mortality in Hospitalized Patients With Methicillin-Resistant Staphylococcus aureus, Candida, and Pseudomonas Bloodstream Infections. Open Forum Infectious Diseases 2020; 7.10.1093\/ofid\/ofaa010697794131993451","DOI":"10.1093\/ofid\/ofaa010"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_024_w2aab3b7b2b1b6b1ab1ac24Aa","doi-asserted-by":"crossref","unstructured":"24. KAWASUJI H, SAKAMAKI I, KAWAMURA T, UENO A, MIYAJIMA Y, MATSUMOTO K, et al. Proactive infectious disease consultation at the time of blood culture collection is associated with decreased mortality in patients with methicillin-resistant Staphylococcus aureus bacteremia: A retrospective cohort study. Journal of Infection and Chemotherapy 2020; 26:588\u201395.10.1016\/j.jiac.2020.01.017","DOI":"10.1016\/j.jiac.2020.01.017"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_025_w2aab3b7b2b1b6b1ab1ac25Aa","doi-asserted-by":"crossref","unstructured":"25. LAGROU K, VAN WIJNGAERDEN E. Infectious disease consultation lowers candidaemia mortality. The Lancet Infectious Diseases 2019; 19:1270\u20132.10.1016\/S1473-3099(19)30522-5","DOI":"10.1016\/S1473-3099(19)30522-5"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_026_w2aab3b7b2b1b6b1ab1ac26Aa","doi-asserted-by":"crossref","unstructured":"26. MOHR A, SIMON M, JOHA T, HANSES F, SALZBERGER B, HITZENBICHLER F. Epidemiology of candidemia and impact of infectious disease consultation on survival and care. Infection 2020; 48:275\u201384. https:\/\/doi.org\/10.1007\/s15010-020-01393-9.10.1007\/s15010-020-01393-932052287","DOI":"10.1007\/s15010-020-01393-9"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_027_w2aab3b7b2b1b6b1ab1ac27Aa","doi-asserted-by":"crossref","unstructured":"27. LEE RA, VO DT, ZURKO JC, GRIFFIN RL, RODRIGUEZ JM, CAMINS BC. Infectious Diseases Consultation Is Associated With Decreased Mortality in Enterococcal Bloodstream Infections. Open Forum Infectious Diseases 2020; 7. https:\/\/doi.org\/10.1093\/ofid\/ofaa064.10.1093\/ofid\/ofaa064707110832190711","DOI":"10.1093\/ofid\/ofaa064"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_028_w2aab3b7b2b1b6b1ab1ac28Aa","doi-asserted-by":"crossref","unstructured":"28. HAMANDI B, HUSAIN S, HUMAR A, PAPADIMITROPOULOS EA. Impact of Infectious Disease Consultation on the Clinical and Economic Outcomes of Solid Organ Transplant Recipients Admitted for Infectious Complications. Clinical Infectious Diseases 2014; 59:1074\u201382. https:\/\/doi.org\/10.1093\/cid\/ciu522.10.1093\/cid\/ciu52225009289","DOI":"10.1093\/cid\/ciu522"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_029_w2aab3b7b2b1b6b1ab1ac29Aa","doi-asserted-by":"crossref","unstructured":"29. SECKIN ZI, BRUMBLE LM, LIBERTIN CR. Serologic screening and infectious disease consultation (IDC): Indicated in heart, lung, liver (HLL) solid organ transplants (SOT) for measles, mumps, rubella, and varicella. Transplant Infectious Disease 2019; 22. https:\/\/doi.org\/10.1111\/tid.13202.10.1111\/tid.1320231647159","DOI":"10.1111\/tid.13202"},{"key":"2026042913132148722_j_rjim-2020-0036_ref_030_w2aab3b7b2b1b6b1ab1ac30Aa","doi-asserted-by":"crossref","unstructured":"30. KASPER AK, PALLOTTA AM, KOVACS CS, SPINNER ML. Infectious diseases consult improves vaccination adherence in kidney transplant candidates. Vaccine 2018; 36:5112\u20135. https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.058.10.1016\/j.vaccine.2018.06.05830049629","DOI":"10.1016\/j.vaccine.2018.06.058"}],"container-title":["Romanian Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/content.sciendo.com\/view\/journals\/rjim\/ahead-of-print\/article-10.2478-rjim-2020-0036\/article-10.2478-rjim-2020-0036.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/rjim-2020-0036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:59:55Z","timestamp":1777485595000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/rjim-2020-0036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,8]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,5,8]]},"published-print":{"date-parts":[[2021,6,1]]}},"alternative-id":["10.2478\/rjim-2020-0036"],"URL":"https:\/\/doi.org\/10.2478\/rjim-2020-0036","relation":{},"ISSN":["2501-062X"],"issn-type":[{"value":"2501-062X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,8]]}}}